300639.SZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 03:04):

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes...

Stats
Today's Volume	10.96M
Average Volume	6.84M
Market Cap	3.90B
EPS	CNY0 ( 2023-10-25 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	9.77
ATR14	CNY0.0100 (0.16%)

Volume Correlation

Long: -0.09 (neutral)

Short: 0.00 (neutral)

Signal:(53.038) Neutral

Guangdong Hybribio Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Guangdong Hybribio Correlation - Currency/Commodity

-0.63
( weak negative )

0.00
( neutral )

-0.33
( neutral )

Guangdong Hybribio Financials

Annual	2022
Revenue:	CNY5.60B
Gross Profit:	CNY3.88B (69.36 %)
EPS:	CNY2.65

Q3	2023
Revenue:	CNY243.99M
Gross Profit:	CNY129.28M (52.98 %)
EPS:	CNY0.0762

Q2	2023
Revenue:	CNY304.52M
Gross Profit:	CNY208.92M (68.61 %)
EPS:	CNY0.0889

Q1	2023
Revenue:	CNY302.11M
Gross Profit:	CNY186.26M (61.65 %)
EPS:	CNY0.0711

Financial Reports:

No articles found.

Guangdong Hybribio

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. Guangdong Hybribio Biotech Co.,Ltd. was founded in 2003 and is based in Sheung Wan, Hong Kong.